Copyright ©The Author(s) 2023.
World J Hepatol. Apr 27, 2023; 15(4): 460-476
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.460
Figure 1
Figure 1 Mechanism of action of immune cells under investigation for recurrence of hepatocellular carcinoma. Early-relapse hepatocellular carcinoma displays decreased regulatory T cells, and higher dendritic cells and CD8+T cells. FoxP3(+) regulatory T cells encourage a gradual decline in CD4+ cytotoxic T cells, which contributes to poorer survival and high recurrence rates. OS: Overall survival; RFS: Relapse-free survival; DC: Dendritic cells; NK: Natural killer cell.